Anne Marie Cook's most recent trade in Sage Therapeutics Inc was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 13,500 | 28,543 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. | 05 Aug 2024 | 4,503 | 24,040 (0%) | 0% | 9.0 | 40,347 | Common Stock |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Marie Anne Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 11,250 | 25,181 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 2,850 | 11,478 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. | 03 Feb 2023 | 980 | 10,498 (0%) | 0% | 44.2 | 43,277 | Common Stock |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 3,800 | 9,010 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. | 19 Oct 2021 | 1,116 | 7,894 (0%) | 0% | 40.3 | 44,964 | Common Stock |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,000 | 6,117 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. | 15 Jun 2021 | 1,144 | 4,973 (0%) | 0% | 58.8 | 67,267 | Common Stock |
| Sage Therapeutics Inc | Anne Marie Cook | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) |